Japan is participating in global drug development at historic levels; however, there is still work to be done there to sustain that growth.
Boston, MA (PRWEB) April 1, 2009
In 2007, drug development in Japan, the world's second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today, Japan: Opening the Door to Global Clinical Trials.
This comprehensive analysis, the fourth in a series of CenterWatch reports on global clinical research markets, takes a look at the reasons for Japan's dramatic growth, the differences in the country's approach to clinical research, and government initiatives to attract Big Pharma to conduct simultaneous global clinical trials in Japan.
"New government initiatives have helped to streamline drug review and approval processes, and sponsor companies have responded by including Japan in their global drug development programs more," said Sara Gambrill, senior editor at CenterWatch and author of the report. "Japan is participating in global drug development at historic levels; however, there is still work to be done there to sustain that growth."
This is an essential resource for any business seeking to better understand Japan's clinical trials landscape and what to expect when conducting clinical research there.
To purchase Japan: Opening the Door to Global Clinical Trials, visit the CenterWatch bookstore at http://store.centerwatch.com.
About Sara Gambrill
Sara Gambrill is senior editor at CenterWatch and writes features about international and domestic clinical research industry trends regularly for The CenterWatch Monthly and CWWeekly. She has also written several special reports on clinical research markets, including Asia-Pacific and Central and Eastern Europe.
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. We provide proprietary data and information about clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. CenterWatch was also the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates. Today, we have one of the largest databases of clinical trials actively seeking patients on the Internet.